Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...

Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

A new study out of the United States could shift how multiple sclerosis (MS) is detected and treated. Researchers say they’ve ...

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The first patient has been dosed in a Phase 1 trial testing the experimental CAR T-cell therapy obecabtagene autoleucel for progressive MS.

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the ...

The new guidance for neurologists comes in updates to the McDonald criteria, the checklist doctors use to diagnose multiple sclerosis.

People with multiple sclerosis (MS) have altered levels of several key bacteria in the mouth, a new study reports.

UCSF study finds MS starts damaging the brain years before symptoms appear. Early immune attack on myelin and key proteins ...

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Cycling for a Cure to End Multiple Sclerosis NEW BERN, NC / ACCESS Newswire / October 28, 2025 / This September, 1,200 cyclists and hundreds of volunteers took part in Bike MS: Historic New Bern Ride, ...